Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay Lucidarme

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
Clinical and Vaccine Immunology : CVI|April 9, 2010
Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccineJay Lucidarme, Maurizio Comanducci, Jamie Findlow, et al.
BMC Infectious Diseases|June 16, 2019
Invasive meningococcal disease in patients with complement deficiencies: a case series (2008-2017)Shamez N Ladhani, Helen Campbell, Jay Lucidarme, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 25, 2025
Use of 4CMenB vaccine in the control of an outbreak of serogroup B invasive meningococcal disease in an elderly care home, England, November 2023Emma J Heymer, Stephen A Clark, Helen Campbell, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 23, 2020
Detection of the United States <i>Neisseria meningitidis</i> urethritis clade in the United Kingdom, August and December 2019 - emergence of multiple antibiotic resistance calls for vigilanceAvril Brooks, Jay Lucidarme, Helen Campbell, et al.
Clinical and Vaccine Immunology : CVI|May 9, 2014
Neisseria adhesin A variation and revised nomenclature schemeStefania Bambini, Matteo De Chiara, Alessandro Muzzi, et al.
The Journal of Infection|August 29, 2020
Geographically widespread invasive meningococcal disease caused by a ciprofloxacin resistant non-groupable strain of the ST-175 clonal complexLaura Willerton, Jay Lucidarme, Helen Campbell, et al.
Msphere|August 24, 2018
Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B <i>Neisseria meningitidis</i> Isolated from 2009 to 2013 in the Republic of IrelandRobert M Mulhall, Desiree Bennett, Robert Cunney, et al.
The Lancet. Public Health|December 19, 2017
Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort studyMirjam J Knol, Susan J M Hahné, Jay Lucidarme, et al.
Human Vaccines & Immunotherapeutics|November 27, 2019
Does vaccination with 4CMenB convey protection against meningococcal serogroup B strains not predicted to be covered by MATS? A study of the UK clonal complex cc269Maria Stella, Maria Giuliani, Alessia Biolchi, et al.
The Journal of Infection|November 28, 2021
Invasive serogroup B meningococci in England following three years of 4CMenB vaccination - First real-world dataJay Lucidarme, Xilian Bai, Aiswarya Lekshmi, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
Clinical and Vaccine Immunology : CVI|April 9, 2010
Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccineJay Lucidarme, Maurizio Comanducci, Jamie Findlow, et al.
BMC Infectious Diseases|June 16, 2019
Invasive meningococcal disease in patients with complement deficiencies: a case series (2008-2017)Shamez N Ladhani, Helen Campbell, Jay Lucidarme, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 25, 2025
Use of 4CMenB vaccine in the control of an outbreak of serogroup B invasive meningococcal disease in an elderly care home, England, November 2023Emma J Heymer, Stephen A Clark, Helen Campbell, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 23, 2020
Detection of the United States <i>Neisseria meningitidis</i> urethritis clade in the United Kingdom, August and December 2019 - emergence of multiple antibiotic resistance calls for vigilanceAvril Brooks, Jay Lucidarme, Helen Campbell, et al.
Clinical and Vaccine Immunology : CVI|May 9, 2014
Neisseria adhesin A variation and revised nomenclature schemeStefania Bambini, Matteo De Chiara, Alessandro Muzzi, et al.
The Journal of Infection|August 29, 2020
Geographically widespread invasive meningococcal disease caused by a ciprofloxacin resistant non-groupable strain of the ST-175 clonal complexLaura Willerton, Jay Lucidarme, Helen Campbell, et al.
Msphere|August 24, 2018
Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B <i>Neisseria meningitidis</i> Isolated from 2009 to 2013 in the Republic of IrelandRobert M Mulhall, Desiree Bennett, Robert Cunney, et al.
The Lancet. Public Health|December 19, 2017
Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort studyMirjam J Knol, Susan J M Hahné, Jay Lucidarme, et al.
Human Vaccines & Immunotherapeutics|November 27, 2019
Does vaccination with 4CMenB convey protection against meningococcal serogroup B strains not predicted to be covered by MATS? A study of the UK clonal complex cc269Maria Stella, Maria Giuliani, Alessia Biolchi, et al.
The Journal of Infection|November 28, 2021
Invasive serogroup B meningococci in England following three years of 4CMenB vaccination - First real-world dataJay Lucidarme, Xilian Bai, Aiswarya Lekshmi, et al.
Pageof 9